The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

Drug coupon aggregator GoodRx and pharmacy benefit managers including CVS Caremark and Express Scripts have been hit with at least three class action lawsuits accusing them of working together to ...

Despite reports this fall that the two payers had reopened merger talks, Cigna plans to use excess cash to buy back its ...

Combining with Express Scripts gave Cigna more tools to help clients control their healthcare costs, and we see significant cross-selling opportunities across their respective books of business. Cigna ...

Cigna (CI) stock gained as company beats Q3 forecasts , driven by Evernorth unit's performance: adjusted income up 5% YoY to $2.1B, revenue at $63.7B. Read more here.

They blame the middlemen in the system: insurance and pharmacy benefit managers. We break it down and explain what is ...

The biggest pharmacy benefit managers are profiting by systematically underpaying independent drugstores, creating “pharmacy deserts” across the country.

In April, the Biden administration finalized a rule that allowed states to cap state-directed payments for Medicaid services at the average commercial rate. The limit is the maximum amount ...

In late September, the Federal Trade Commission (FTC) said that it had taken legal action against the three largest PBMs (CVS Health’s Caremark, Cigna’s Express Scripts, and UnitedHealth’s ...

3 The FTC filed an administrative complaint that targets CVS Health’s Caremark, Cigna’s Express Scripts, and UnitedHealth’s Optum Rx, as well as any subsidiaries they have created to manage ...